← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Ambroxolo acefillinato currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: AMBROXOLO ACEFILLINATO · data refreshed 5 September 2026
As of 5 September 2026, 1 of the 9 tracked registers list current availability issues for Ambroxolo acefillinato, covering 3 affected product presentations. The longest-running open report was filed in Italy on 2024-12-20 and has now been open for about 21 months. Where agencies state a cause, manufacturing problems lead with 2 of the 3 stated-cause reports, followed by commercial decisions or discontinuation with 1. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage AMBROMUCIL + 2 more productsAMBROMUCIL SURFOLASE | 2024-12-20 | — | Elevata richiesta/problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Ambroxolo acefillinato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | SURFOLASE | Shortage | 2026-03-18 | — | Cessata commercializzazione definitiva |
| 🇮🇹 IT | AMBROMUCIL | Shortage | 2025-12-08 | — | Problemi produttivi (carenza relativa solo al canale retail) |
| 🇮🇹 IT | AMBROMUCIL | Shortage | 2024-12-20 | — | Elevata richiesta/problemi produttivi |
Yes. As of 5 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Ambroxolo acefillinato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ambroxolo acefillinato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ambroxolo-acefillinato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ambroxolo acefillinato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ambroxolo-acefillinato/">Ambroxolo acefillinato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>